M
All subjects enrolled in the present study provided written informed consent. The present study was approved by the Ethics Committee of the National Cardiovascular Center and by the Committee on Genetic Analysis and Gene Therapy of the National Cardiovascular Center. Subjects with a systolic blood pressure (SBP) ≥140mmHg, diastolic blood pressure ≥90 mmHg and/or taking antihypertensive medication were categorized as having hypertension. 3 Subjects with a fasting blood glucose ≥126 mg/dl, hemoglobin (Hb) A1c ≥6.5% and/or undergoing treatment for diabetes mellitus (DM) were categorized as having DM. 3 Subjects with total cholesterol ≥220 mg/dl, triglycerides ≥150 mg/dl and/or taking antihyperlipidemic medication were categorized as having hyperlipidemia. 3 The intimamedia thickness (IMT), a well-known indicator of coronary atherosclerosis, was measured on a longitudinal scan of the common carotid artery at a point 10 mm proximal from the beginning of the dilation of the bulb. 7 
DNA Study
Ozaki et al determined 8 polymorphisms in PSMA6 genes, and found the most significant association with MI at the polymorphism rs1048990. 4 In the present study, we determined the rs1048990 polymorphism using the TaqMan methods. The following polymerase chain reaction primer and probe set was used: C_11599359_10 (Applied Biosystems, Foster City, USA).
Statistical Analysis
The values are expressed as mean ± standard deviation. All statistical analyses were performed with the JMP statistical package (SAS Institute Inc, Cary, NC, USA). Simple correlation analyses and logistic analyses were performed to determine the association between laboratory data and MI cases. Multiple logistic analyses were performed to obtain predictors for MI. Odds ratio and 95% confidence intervals (CI) were also calculated. The continuous phenotypic variables and genotype were compared using one way analysis of variance, adjusting for appropriate confounding factors. Residuals of IMT were calculated by adjusting for age, SBP, sex and body mass index (BMI). 9 C reactive protein (CRP) levels were logarithmically transformed to attain normal distribution.
Results
The characteristics of the present study population are shown in Table 1 . In the present study population, the frequencies of the GG genotype in the MI and the control group were 10.6% and 9.8%, respectively (Table 2) . No significant difference was observed in the genotype frequency between the 2 groups. The GG genotype was not associated with smoking habits or the prevalence of DM ( Table 2 ). The odds ratio of the GG genotype of PSMA6 over the CC + CG genotype for MI was 0.97 (95% CI, 0.63-1.44) (Table 3 ). However, because it was possible that the sample size of the MI group (n=433) was too small to detect the small effects of the risk-conferring alleles, we observed the effects of this genotype on carotid IMT, an excellent noninvasive marker of atherosclerosis. The GG genotype was associated with mean IMT (p=0.025) and greater residuals of mean IMT (p=0.015) after adjusting for age, BMI, sex and SBP (Table 4) .
No significant effects from this genotype on CRP levels were observed in the Suita population (Table 5 ).
Discussion
The purpose of the present study was to validate in our study population the association between PSMA6 variants and MI that has been reported in a Japanese population. Because the genetic contribution of a single gene to common disease susceptibility appears to be low, as observed in the insertion/deletion polymorphism of the angiotensin converting enzyme gene in cardiovascular disease, validation studies in other study populations are important. 12, 13 PSMA6 encodes the proteasome subunit type 6, a component of the 20S proteasome. 14 The 20S proteasome is composed of 7 and 10 subunits, and is the core particle for the 26S ubiquitin-proteasome system, which is important in the regulation of the abundance of proteins involved in various cellular functions, including inflammation. [15] [16] [17] Of note, this system is involved in the degradation of the I B protein, which inhibits the activation of NF-B, a central transcriptional factor that regulates the expression of genes related to inflammation. 5 Now vascular inflammation is considered a key player for atherogenesis, and CRP levels are a well-known predictor for subsequent MI. [18] [19] [20] [21] The reported odds ratio of the GG genotype of PSMA6 over the CC + CG genotype for MI was just 1.36 (95% CI, 1.12-1.65). 4 Thus, we were unable to detect the association of the GG genotype with MI, probably due to our small sample size. However, we did detect an influence of this genotype on IMT, a well-known index of atherosclerosis of coronary arteries. [22] [23] [24] [25] This may indicate that the influence of this gene may be directed to the pathogenesis of atherosclerosis. The influence of the PSMA6 genotype on the residuals of IMT-mean was significant but slight (r 2 =0.0042, p=0.014). The IMT-maximum values may be considered to be more influenced by local micro environmental factors and may be difficult to predict using classical risk factors. Indeed, the r 2 values for IMT-maximum by confounding factors (age, gender, SBP and HbA1c) was 0.181, which is smaller than the r 2 values for IMT-mean (r 2 =0.237) by confounding factors (age, gender, BMI, SBP and HbA1c). Therefore, a slight influence of the PSMA6 genotype may not be detected in the IMT-maximum.
Ozaki et al reported that the frequencies of the genotype GG in the MI and the control groups were 12.4% and 8.9%, respectively. 4 However, in the present study population, the frequencies of the GG genotype in the MI and the control group were 10.6% and 9.7%, respectively, with no significant differences between groups. Ozaki et al speculated that the effects of PMSA6 might be due to potentiation of inflammation. 4 CRP levels are known to be a good indicator of future MI. 20 However, in the present study, the GG genotype was not associated with the CRP levels. The precise mechanism of how the GG genotype might accelerate atherosclerosis or infarction awaits further investigation.
In conclusion, the reported genotype in PSMA6 appears not to contribute appreciably to MI, but may contribute slightly to atherosclerosis in the present study population.
